Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
October 10, 2024
CAMP4 Announces Pricing of Initial Public Offering
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
August 3, 2022
In the News
GEN Edge
Mountain Climbing: CAMP4 Aims to Scale the Heights of Disease
July 28, 2022
In the News
Business Insider
Meet the 23 Biotech Startups that are set to take off in the next 12 months, according to VCs
July 20, 2022
In the News
Boston Globe
Cambridge startup CAMP4 Therapeutics raises $100 million for RNA therapies
July 20, 2022
In the News
Boston Globe
Cambridge startup CAMP4 Therapeutics raises $100 million for RNA therapies
July 20, 2022
In the News
BioCentury
Patient Square’s Enavate backs Camp4 in $100M series B, driving push to clinic
July 20, 2022
In the News
Business Insider
See the 18-slide pitch deck a genetics startup used to raise $100 million and explore ‘the dark side’ of the genome
July 20, 2022
In the News
Endpoints
With a fresh $100M in hand, one RNA startup is moving to the clinic, finding partners and building a new lab — all at once
July 20, 2022
In the News
Fierce Biotech
Equipped with fresh $100M, CAMP4 heads up trail to the clinic, hoping partners will soon tag along
1
2
3
»
Media Contact:
PR@camp4tx.com
Top